SEP 10, 2019 3:33 PM PDT

Does Modafinil Really Increase Brain Function?

WRITTEN BY: Annie Lennon

Modafinil, often sold under the name 'Provigil', is a wakefulness-promoting drug used to treat excessive sleeping in conditions such as narcolepsy and obstructive sleep apnea. However, some also use it as a cognitive enhancer to improve focus, memory, and executive functioning (ALZ Discovery: 2019). But how does it work? And does it really boost brain function? 

Exactly how modafinil works is unknown. However, it seems to have a significant impact on several neurotransmitters, including serotonin and glutamate, as well as the brain's histamine systems, all responsible for regulating mood, learning, and memory. In particular, it is thought to directly alter the concentration of catecholamines, such as adrenaline and dopamine, in the brain in a way thought to enhance executive functioning and focus (Minzenberg: 2008).

Despite these supposed effects, however, studies show that the real effects of modafinil are inconsistent and vary according to the user's prior health. While a systematic review of studies measuring the effects of drug effects between 1990 and 2014 on healthy individuals demonstrated increased performance in demanding tasks, a more recent study contradicted these findings. In this study, researchers found that although the drug may have helped the students complete non-demanding tasks, few positive effects were seen on more demanding tasks such as studying (Fernandez: 2015).

Despite this, more positive results have been found among people with preexisting health issues- in this case: remitted depression. In a double-blind, placebo-controlled study from 2017, researchers monitored 60 participants either on a single dose of 200mg of modafinil, or a placebo, for changes in their cognitive function. Drawing conclusions from both neurocognitive tests and the participants' subjective feelings during the trial, the researchers found that the modafinil group performed significantly better on tests for episodic memory and working memory. Despite these improvements, however, they found that modafinil had little effect on planning or sustained attention (Kaser: 2017). 

As most of these trials tested only for a single dosage of modafinil over a short period, further research is necessary to establish more concrete results for both healthy individuals and those with preexisting conditions (Loria: 2016). Due to a lack of funding for cognitive enhancement for healthy people, however, evidence on its benefits, at least for healthy individuals, may continue to come from either smaller-scale studies or anecdotal evidence.

To conclude, it appears that although modafinil may increase certain aspects of cognitive functioning, its results in healthy people vary and appear stronger for those with preexisting issues. Despite some awareness of the neurological processes the drug affects and interacts with, how exactly it impacts the brain is still unknown. Thus, even though anecdotal evidence may still encourage modafinil usage for its cognition-enhancing effects, more research is needed to understand to what extent it actually works. 

 

Sources

 

ALZ Discovery 

Minzenberg, MJ et al.: Pub Med 

Fernandez, A et al.: Pub Med

Kaser, Muzaffer et al: US National Library of Medicine 

Battleday, RM et al.: US National Library of Medicine 

Loria, Kevin: Business Insider 

About the Author
  • Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
AUG 01, 2021
Drug Discovery & Development
New Compound Halts Neurodegeneration in Alzheimer's
AUG 01, 2021
New Compound Halts Neurodegeneration in Alzheimer's
Chemists have synthesized new compounds that can halt neurodegeneration linked to Alzheimer’s and other neurologic ...
AUG 17, 2021
Clinical & Molecular DX
Sleep Apnea Doubles the Risk of Sudden Death
AUG 17, 2021
Sleep Apnea Doubles the Risk of Sudden Death
Obstructive sleep apnea, or OSA, is the most commonly reported sleep disorder, with loud snoring being one of the tell-t ...
AUG 24, 2021
Drug Discovery & Development
A comparison of drugs for relapsing-remitting multiple sclerosis.
AUG 24, 2021
A comparison of drugs for relapsing-remitting multiple sclerosis.
     Multiple sclerosis (MS) is a rare and unpredictable autoimmune disease in which the body’s inn ...
SEP 23, 2021
Immunology
Enhanced Hamster Cells as Super Drug Factories
SEP 23, 2021
Enhanced Hamster Cells as Super Drug Factories
Antibodies are highly specialized proteins produced by the immune system that stick on to foreign invaders in the body w ...
OCT 07, 2021
Drug Discovery & Development
Extended approval for a drug to treat children living with HIV
OCT 07, 2021
Extended approval for a drug to treat children living with HIV
On Monday October 4th, ViiV Healthcare announced that it had submitted an application to the United States Food and Drug ...
OCT 12, 2021
Immunology
Major Landmark in a 100-Year Search for a Malaria Vaccine
OCT 12, 2021
Major Landmark in a 100-Year Search for a Malaria Vaccine
In one of the greatest global health milestones of our time, the World Health Organization has approved the widespread d ...
Loading Comments...